Ophthalmic Imaging Market: Growth, Size, Share, and Trends
Ophthalmic Imaging Market by Product Type (Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras), Application (Glaucoma, Retinopathies), End User (Hospitals, Ophthalmology Clinics, Optometry Clinics) - Global Forecast to 2030
USD 3.84 BN
MARKET SIZE, 2030
CAGR 6.3%
(2025-2030)
245
REPORT PAGES
354
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The ophthalmic imaging market is experiencing significant growth, this growth is driven by the increasing prevalence of ocular disorders, advancements in imaging technologies, and the integration of artificial intelligence (AI) for enhanced diagnostic accuracy. Additionally, the rising demand for portable imaging devices and tele-ophthalmology services is further propelling market expansion
KEY TAKEAWAYS
-
BY TECHNOLOGYBased on technology, the ophthalmic imaging market is divided into AI enabled equipment and Non AI enabled equipment. In 2024, the Non AI enabled equipmet segment held the largest share of the global ophthalmic imaging market. Hospitals and clinics continue to rely on these traditional imaging systems for routine diagnostics, retinal assessments, and glaucoma monitoring, supporting steady adoption globally.
-
BY PRODUCTBased on product, the market of ophtalmic imaging market is divided into optical coherence tomography systems, ophthalmic ultrasound systems, fundus cameras, slit lamps, specular microscopes, tonometers, ophthalmoscopes, retinoscopes, other ophthalmic imaging equipment. In 2024, the optical coherence tomography systems segment held the largest share of the global ophtalmic imaging market. Their extensive use in detecting conditions like macular degeneration and diabetic retinopathy drives strong adoption across hospitals and specialized eye clinics globally.
-
BY APPLICATIONBased on application, the ophthalmic imaging market has been categorized into glaucoma, cataracts, retinopathies, refractive disorders, age-related macular degeneration, other application. In 2024, glaucoma held the largest market share in the ophthalmic imaging market. Advanced imaging modalities like OCT and fundus photography play a key role in assessing optic nerve damage, driving demand for glaucoma-related diagnostic imaging solutions.
-
BY END USERThe ophthalmic imaging market has been categorized by end user into hospitals, ophthalmology clinics, optometry clinics, other end user. Hospitals hold the largest share of the ophthalmic imaging market due to the high patient influx and availability of advanced diagnostic infrastructure. They offer comprehensive eye care services, including screening and management of retinal disorders and glaucoma, supported by skilled ophthalmologists and integrated imaging systems for accurate diagnosis and treatment planning.
-
BY REGIONDuring the forecast period, the Asia Pacific region is projected to record the highest growth rate in the ophthalmic imaging market. This surge is driven by growing prevalence of eye disorders (diabetic retinopathy, cataracts, glaucoma), expanding aging populations, increasing healthcare expenditure, advances in imaging technology (e.g. OCT, fundus cameras), and efforts to improve healthcare infrastructure plus wider adoption of tele-ophthalmology in underserved rural areas.
-
COMPETITIVE LANDSCAPEThe major market players have adopted organic and inorganic strategies, including partnerships, collaborations, and approvals. For instance, Topcon Corporation (Japan) and Moorfields Eye Hospital, UCL Institute of Ophthalmology launched Cascader Limited to advance AI-driven eyecare and Oculomics. a new medical technology company that aims to transform the detection and management of eye disease through artificial intelligence (AI). Cascader also builds on the growing field of Oculomics – the use of advanced retinal imaging to uncover insights into systemic conditions.
The ophthalmic imaging market is driven by the rising prevalence of eye diseases and an aging global population, which boosts demand for advanced diagnostic tools. Significant technological advancements, such as AI integration and portable imaging devices, further accelerate adoption. However, high costs of equipment and reimbursement challenges in certain regions act as major restraints, limiting accessibility and implementation, especially in low-resource settings. Key opportunities include the expansion of tele-ophthalmology, increased healthcare investments in emerging economies, and the growing need for early, accurate detection of vision-threatening conditions.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The ophthalmic imaging market is witnessing rapid transformation driven by the growing prevalence of eye diseases, technological advancements, and the increasing need for early and accurate diagnosis. Conventional tools like fundus cameras and slit lamps are now being complemented or replaced by advanced imaging technologies such as optical coherence tomography (OCT), ophthalmic ultrasound, and corneal topography systems. These innovations allow for enhanced image resolution, faster diagnostics, and integration with AI for predictive analytics. New high-growth opportunities are emerging through AI-integrated imaging systems, portable and handheld OCT/ultrasound devices, and cloud-enabled diagnostic platforms, which are enabling access to eye care in remote and underserved regions. This transition is also reshaping business models, as end users—including hospitals, ophthalmology clinics, and optometry practices—increasingly demand connected, scalable, and interoperable solutions to improve diagnostic accuracy and workflow efficiency. These shifts are encouraging companies to invest in automation, digitalization, and smart imaging ecosystems to stay competitive.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Growing Prevalence of Eye Disorders and Aging Population
-
Technological Advancements in Imaging Modalities
RESTRAINTS
Impact
Level
Level
-
High Capital Cost of Imaging Equipment
-
Maintenance and Downtime of High-End Systems
OPPORTUNITIES
Impact
Level
Level
-
Expansion in Emerging Markets
-
AI-Enabled Screening and Workflow Optimization
CHALLENGES
Impact
Level
Level
-
Shortage of Skilled Ophthalmic Technicians and Clinicians
-
Data Privacy and AI Regulation Challenges
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing Prevalence of Eye Disorders and Aging Population
The growing prevalence of eye disorders and aging populations is a major driver of the ophthalmic imaging market. Conditions like AMD, diabetic retinopathy, and glaucoma require early diagnosis and regular monitoring. With over 2.2 billion people affected by visual impairment globally, the need for advanced imaging tools such as OCT and fundus cameras is rising. Demand is particularly high in aging regions like Japan, Germany, and Italy. Rising diabetes cases and longer life expectancy further drive market growth, supported by ongoing technological advancements in imaging modalities.
Restraint: High Capital Cost of Imaging Equipment
The high capital cost of ophthalmic imaging equipment, often ranging from USD 30,000 to 80,000, limits adoption in low-resource settings and small clinics. Additional expenses for installation, training, and maintenance add to the burden. While large hospitals can absorb these costs, clinics in regions like Sub-Saharan Africa and Southeast Asia struggle. Limited financing and outdated diagnostic reliance further hinder access. Although portable and affordable solutions are emerging, affordability and public health funding gaps remain major restraints on broader market penetration.
Opportunity: Expansion in Emerging Markets
Emerging markets like India, Brazil, and Southeast Asia offer strong growth potential for ophthalmic imaging due to large populations, rising eye disease prevalence, and increasing healthcare investments. However, limited access to advanced tools in rural areas hinders early diagnosis. Governments, NGOs, and companies like Remidio and Forus Health are addressing this through portable, AI-enabled imaging devices. Public-private partnerships and evolving reimbursement systems are further boosting adoption, improving access, and driving long-term growth for manufacturers in the ophthalmic imaging space.
Challenge: Shortage of Skilled Ophthalmic Technicians and Clinicians
The shortage of skilled ophthalmic technicians and clinicians hampers the effective use of advanced ophthalmic imaging systems, impacting diagnostic accuracy and patient outcomes. This problem is acute in countries like India, Brazil, and Mexico, especially in rural areas with limited training access. The lack of standardized certification and continuing education further widens the skills gap. While modular training programs and AI tools are being developed, workforce shortages continue to restrict the expansion of ophthalmic imaging services in high-need regions.
Ophthalmic Imaging Market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Developer of diagnostic and surgical ophthalmic imaging systems including OCT and fundus cameras. | Provides highly accurate imaging and analysis for glaucoma, cataracts, and macular degeneration, improving patient management and surgical precision. |
 |
Manufacturer of ophthalmic diagnostic instruments, including fundus cameras and slit lamps. | Enhances digital imaging capabilities and workflow integration, supporting early detection of retinal and refractive disorders. |
|
|
Provider of advanced ophthalmic equipment such as tonometers and refraction systems. | Offers versatile imaging solutions for both clinics and hospital settings, improving diagnostic efficiency. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem of the ophthalmic imaging market is a highly collaborative and interconnected network comprising component suppliers, imaging system manufacturers, academic and research institutions, regulators, distributors, investors, and end users. These stakeholders collectively contribute to the advancement, regulatory approval, commercialization, and adoption of ophthalmic diagnostic technologies. The ecosystem spans from early-stage R&D—focusing on innovations in optical systems, image processing, and AI diagnostics—to large-scale manufacturing, international distribution, and clinical implementation. The synergy between universities, imaging labs, regulatory agencies, private investors, and care providers shapes the speed of innovation and the reach of imaging solutions globally. Ecosystem performance hinges on timely investment, seamless cross-border regulatory alignment, and user education to ensure accurate diagnostics. Understanding this ecosystem helps identify gaps in access, prioritize strategic partnerships, and implement sustainable delivery models that ensure the early detection and monitoring of vision-threatening disorders across diverse care settings.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Ophthalmic Imaging Market, By Technology
Non-AI-enabled ophthalmic imaging equipment will hold the largest market share due to its widespread availability, lower cost, and established use in routine eye care. Many clinics, especially in developing regions, continue to rely on traditional systems like standard OCT and fundus cameras. Their proven effectiveness, ease of use, and compatibility with existing workflows support sustained dominance in the current market
Ophthalmic Imaing Market, By Product
OCT systems hold the largest market share in the ophthalmic imaging market due to their ability to deliver high-resolution, cross-sectional images essential for diagnosing retinal and optic nerve disorders. Widely used for conditions like glaucoma and AMD, their non-invasive nature and integration with AI technologies drive widespread clinical adoption and continued market dominance.
Ophthalmic Imaing Market, By Application
Glaucoma holds the largest share of the ophthalmic imaging market due to several factors. The increasing global prevalence of glaucoma, especially among the aging population, drives demand for early detection and continuous monitoring. Advanced imaging modalities like Optical Coherence Tomography (OCT) and fundus cameras enable precise assessment of optic nerve damage and intraocular pressure changes. Rising awareness among patients and healthcare providers, coupled with the availability of specialized diagnostic facilities in hospitals and eye clinics, further fuels the adoption of ophthalmic imaging for glaucoma management worldwide.
Ophthalmic Imaing Market, By End User
Hospitals hold the largest market share in the ophthalmic imaging market by end users because they routinely manage complex eye conditions and high patient volumes. With access to advanced diagnostic equipment like OCT and fundus imaging, well-trained specialists, and favorable reimbursement systems, hospitals drive strong, sustained demand for ophthalmic imaging devices
REGION
Asia Pacific to be fastest-growing region in global oxygen concentrators market during forecast period
The Asia-Pacific ophthalmic imaging market is projected to grow at the highest CAGR due to multiple factors. Rising prevalence of eye disorders such as glaucoma, diabetic retinopathy, and age-related macular degeneration is driving demand for advanced diagnostics. Technological advancements in imaging systems like OCT, a rapidly aging population, and increasing healthcare infrastructure investments in countries like China, India, and Japan further support growth. Additionally, government initiatives promoting healthcare access and affordability are boosting adoption, making the region a key growth hub globally.
Ophthalmic Imaging Market: COMPANY EVALUATION MATRIX
In the ophthalmic imaging market, Carl Zeiss Meditec AG (Star) has a strong and established product portfolio and a vast geographic presence. Visionix (Emerging Leader) has substantial product innovations compared to its competitors. While they have broad product portfolios, they do not have a strong growth strategy for business development.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2024 (Value) | USD 2.69 BN |
| Revenue Forecast in 2030 (Value) | USD 3.84 BN |
| Growth Rate | 6.30% |
| Years Considered | 2023–2030 |
| Base Year | 2024 |
| Forecast Period | 2025–2030 |
| Units Considered | Value (USD MN), Volume (Thousand Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered | By Technology: AI enabled equipment and Non AI enabled equipment By Product: Optical Coherence Tomography systems, Ophthalmic Ultrasound Systems, Fundus Cameras, Slit Lamps, Specular Microscopes, Tonometers, Ophthalmoscopes, Retinoscopes, Other Ophthalmic Imaging Equipment By Application: Glaucoma, Cataracts, Retinopathies, Refractive Disorders, Age-Related Macular Degeneration, Other Application By End User: Hospitals, Ophthalmology Clinics, Optometry Clinics, Other End User |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries |
WHAT IS IN IT FOR YOU: Ophthalmic Imaging Market REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Comparison of ophthalmic imaging devices: Optical Coherence Tomography (OCT) systems, Fundus Cameras, Slit Lamps, Ophthalmic Ultrasound Systems, Specular Microscopes, Tonometers, Ophthalmoscopes, and other imaging solutions. | Analysis of product innovations such as AI-enabled diagnostics, multimodal imaging integration, and automated retinal disease detection. |
| Company Information | Profiles of key ophthalmic imaging players such as Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), NIDEK Co., Ltd. (Japan), Alcon Inc. (Switzerland), Optopol Technology Sp. z o.o (Poland), Essilor International S.A. (France), Bausch & Lomb Incorporated (US), Visionix (France), Heidelberg Engineering GmbH (Germany), and Halma Plc (UK). | Market share benchmarking and competitive landscape analysis of top 3–5 players across North America, Europe, Asia Pacific, and the Middle East. |
| Geographic Analysis | Detailed regional analysis of North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. | Country-level sizing and growth forecasts for key markets such as the US, Germany, Japan, China, India, and Brazil. |
RECENT DEVELOPMENTS
- May 2025 : Topcon Corporation (Japan) and Moorfields Eye Hospital, UCL Institute of Ophthalmology launched Cascader Limited to advance AI-driven eyecare and Oculomics. a new medical technology company that aims to transform the detection and management of eye disease through artificial intelligence (AI). Cascader also builds on the growing field of Oculomics – the use of advanced retinal imaging to uncover insights into systemic conditions
- May 2025 : Topcon Corporation (Japan) announced a strategic investment into Pangaea Data, a health AI company specializing in identifying untreated and under-treated patients at scale, The collaboration aims to accelerate the application of Pangaea’s clinically validated AI platform to address critical care gaps in eye health and systemic disease.
- October 2023 : Carl Zeiss Meditec AG (Germany) and Boehringer Ingelheim (Germany) collaborated to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases
- April 2023 : Carl Zeiss Meditec AG (Germany) and Boehringer Ingelheim (Germany) collaborated to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
TABLE OF CONTENTS
1
INTRODUCTION
33
2
RESEARCH METHODOLOGY
38
3
EXECUTIVE SUMMARY
53
4
PREMIUM INSIGHTS
57
5
MARKET OVERVIEW
AI-driven imaging innovations and emerging markets propel ophthalmic industry growth despite high costs and skill gaps.
61
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
Growing prevalence of chronic eye diseases among geriatric patients
5.2.1.2
Technological advancements in imaging modalities
5.2.1.3
Favorable government initiatives and better reimbursement support
5.2.2
RESTRAINTS
5.2.2.1
High capital cost of ophthalmic imaging equipment
5.2.2.2
High maintenance costs and increased downtime of high-end systems
5.2.3
OPPORTUNITIES
5.2.3.1
High growth opportunities in emerging economies
5.2.3.2
Focus on AI-enabled screening and workflow optimization
5.2.4
CHALLENGES
5.2.4.1
Shortage of skilled ophthalmic technicians and clinicians
5.2.4.2
Data privacy and AI regulation challenges
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4
PRICING ANALYSIS
5.4.1
AVERAGE SELLING PRICE OF OPHTHALMIC IMAGING PRODUCTS, BY TYPE, 2024
5.4.2
AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024
5.5
VALUE CHAIN ANALYSIS
5.6
SUPPLY CHAIN ANALYSIS
5.7
ECOSYSTEM ANALYSIS
5.7.1
ROLE IN ECOSYSTEM
5.8
INVESTMENT & FUNDING SCENARIO
5.9
TECHNOLOGY ANALYSIS
5.9.1
KEY TECHNOLOGIES
5.9.1.1
Fluorescein angiography
5.9.1.2
Ultrasound B-scan imaging
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.2.1
Artificial intelligence and deep learning
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.1
Smartphone-based retinal imaging
5.9.3.2
Gene therapy & retinal implants
5.10
INDUSTRY TRENDS
5.10.1
RAPID SHIFT TOWARD MULTIMODAL AND AI-INTEGRATED IMAGING SYSTEMS
5.10.2
INCREASED PENETRATION OF PORTABLE AND HANDHELD IMAGING SOLUTIONS
5.10.3
PREMIUM IMAGING GROWTH TO GET HIGH CAPITAL INVESTMENTS IN HOSPITALS AND TERTIARY CARE CENTERS
5.10.4
OEM CONSOLIDATION AND SOFTWARE-DRIVEN ECOSYSTEMS TO RESHAPE COMPETITIVE LANDSCAPE
5.11
PATENT ANALYSIS
5.12
TRADE ANALYSIS
5.12.1
IMPORT DATA FOR HS CODE 901850, 2020–2024
5.12.2
EXPORT DATA FOR HS CODE 901850, 2020–2024
5.13
KEY CONFERENCES & EVENTS, 2025–2026
5.14
CASE STUDY ANALYSIS
5.14.1
ZEISS TO ENHANCE CIRRUS HD-OCT PLATFORM BY INTEGRATING AI-BASED TOOLS FOR DETECTING GLAUCOMA AND RETINAL DISEASES
5.14.2
INDIA’S NATIONAL PROGRAM FOR CONTROL OF BLINDNESS (NPCB) TO COLLABORATE WITH FORUS HEALTH FOR REDUCING AVOIDABLE BLINDNESS
5.14.3
UK NATIONAL HEALTH SERVICE TO DEPLOY HEIDELBERG ENGINEERING’S SPECTRALIS OCT PLATFORM FOR IMPROVING EARLY DETECTION OF CHRONIC DISEASES
5.15
REGULATORY ANALYSIS
5.15.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15.2
REGULATORY FRAMEWORK
5.15.2.1
North America
5.15.2.2
Europe
5.15.2.3
Asia Pacific
5.15.2.4
Latin America
5.15.2.5
Middle East & Africa
5.16
PORTER’S FIVE FORCES ANALYSIS
5.16.1
BARGAINING POWER OF SUPPLIERS
5.16.2
BARGAINING POWER OF BUYERS
5.16.3
THREAT OF NEW ENTRANTS
5.16.4
THREAT OF SUBSTITUTES
5.16.5
INTENSITY OF COMPETITIVE RIVALRY
5.17
KEY STAKEHOLDERS & BUYING CRITERIA
5.17.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.17.2
KEY BUYING CRITERIA
5.18
UNMET NEEDS/END-USER EXPECTATIONS
5.19
IMPACT OF 2025 US TARIFF ON OPHTHALMIC IMAGING MARKET
5.19.1
KEY TARIFF RATES
5.19.2
PRICE IMPACT ANALYSIS
5.19.3
KEY IMPACT ON COUNTRY/REGION
5.19.3.1
North America
5.19.3.2
Europe
5.19.3.3
Asia Pacific
5.19.4
IMPACT ON END-USE INDUSTRIES
5.20
IMPACT OF AI/ GEN AI ON OPHTHALMIC IMAGING MARKET
5.21
ADJACENT MARKET ANALYSIS
6
OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
99
6.1
INTRODUCTION
6.2
AI-ENABLED EQUIPMENT
6.2.1
RISING DEMAND FOR EARLY DIAGNOSIS, EFFICIENCY, AND STANDARDIZATION TO DRIVE MARKET
6.3
NON-AI-ENABLED EQUIPMENT
6.3.1
ESTABLISHED CLINICAL UTILITY AND COST-EFFECTIVENESS TO SUSTAIN DOMINANCE
7
OPHTHALMIC IMAGING MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 62 Data Tables
106
7.1
INTRODUCTION
7.2
OPTICAL COHERENCE TOMOGRAPHY SYSTEMS
7.2.1
SPECTRAL-DOMAIN OCT (SD-OCT)
7.2.1.1
Growing demand for high-resolution retinal imaging to accelerate market adoption
7.2.2
SWEPT-SOURCE OCT (SS-OCT)
7.2.2.1
Rising preference for deep tissue imaging and faster scanning to fuel market growth
7.2.3
HANDHELD OCT
7.2.3.1
Surging demand for portability and pediatric imaging to propel market growth
7.3
OPHTHALMIC ULTRASOUND SYSTEMS
7.3.1
OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS
7.3.1.1
Rising prevalence of cataracts and increasing intraocular lens (IOL) implantation procedures to aid market growth
7.3.2
OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS
7.3.2.1
Rising incidence of retinal disorders and opaque media cases to augment segment growth
7.3.3
OPHTHALMIC ULTRASOUND BIOMICROSCOPES
7.3.3.1
Demand for high-resolution anterior segment imaging to fuel market growth
7.3.4
OPHTHALMIC PACHYMETERS
7.3.4.1
Growing incidence of glaucoma and increasing demand for refractive surgery to support segment growth
7.3.5
OTHER OPHTHALMIC ULTRASOUND SYSTEMS
7.4
FUNDUS CAMERAS
7.4.1
MYDRIATIC FUNDUS CAMERAS
7.4.1.1
Advancements in retinal disease diagnosis and imaging precision to boost market growth
7.4.2
NON-MYDRIATIC FUNDUS CAMERAS
7.4.2.1
Rising diabetic retinopathy screening and growing focus on primary eye care to augment market growth
7.4.3
HYBRID FUNDUS CAMERAS
7.4.3.1
Demand for versatile retinal imaging and workflow efficiency to fuel market adoption
7.4.4
ROP FUNDUS CAMERAS
7.4.4.1
Urgent need for early detection of retinal disorders in newborns to propel segment growth
7.5
SLIT LAMPS
7.5.1
HANDHELD SLIT LAMPS
7.5.1.1
Portability, tele-ophthalmology, and field screening to fuel market demand
7.5.2
TABLE MOUNT SLIT LAMPS
7.5.2.1
Focus on precision diagnostics and need for better image clarity to augment market growth
7.6
SPECULAR MICROSCOPES
7.6.1
RISING NUMBER OF CORNEAL TRANSPLANTS AND CATARACT SURGERIES TO ACCELERATE MARKET DEMAND
7.7
TONOMETERS
7.7.1
APPLANATION TONOMETERS
7.7.1.1
Widespread clinical acceptance and diagnostic accuracy to aid market growth
7.7.2
REBOUND TONOMETERS
7.7.2.1
Adoption of rebound tonometers to gain preference for better portability and greater patient comfort
7.8
OPHTHALMOSCOPES
7.8.1
DIRECT OPHTHALMOSCOPES
7.8.1.1
Technological upgrades to sustain global demand for direct ophthalmoscopes
7.8.2
INDIRECT OPHTHALMOSCOPES
7.8.2.1
Growing demand in retinal care to increase product demand
7.9
RETINOSCOPES
7.9.1
RISING DEMAND AMONG PEDIATRIC, NON-VERBAL, AND UNCOOPERATIVE PATIENTS TO SUSTAIN DEMAND
7.10
OTHER OPHTHALMIC IMAGING PRODUCTS
8
OPHTHALMIC IMAGING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 7 Data Tables
151
8.1
INTRODUCTION
8.2
GLAUCOMA
8.2.1
NEED FOR EARLY DETECTION AND LONG-TERM MONITORING TO FUEL ADOPTION OF ADVANCED IMAGING MODALITIES
8.3
CATARACTS
8.3.1
INCREASING CATARACT SURGERIES AND PREOPERATIVE IMAGING TO SPUR DEMAND FOR DIAGNOSTIC OPHTHALMIC SYSTEMS
8.4
RETINOPATHIES
8.4.1
RISING DIABETIC AND HYPERTENSIVE POPULATION TO ACCELERATE DEMAND FOR ADVANCED RETINAL IMAGING SOLUTIONS
8.5
REFRACTIVE DISORDERS
8.5.1
RISING DEMAND FOR REFRACTIVE SURGERIES TO BOOST UPTAKE OF ADVANCED IMAGING SYSTEMS FOR PREOPERATIVE PLANNING
8.6
AGE-RELATED MACULAR DEGENERATION
8.6.1
AGING DEMOGRAPHICS AND INCREASED LIFESPAN TO PROPEL PREVALENCE OF AGE-RELATED MACULAR DEGENERATION
8.7
OTHER APPLICATIONS
9
OPHTHALMIC IMAGING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 5 Data Tables
159
9.1
INTRODUCTION
9.2
HOSPITALS
9.2.1
RISING ADOPTION OF ADVANCED OPHTHALMIC DIAGNOSTICS TO AUGMENT MARKET GROWTH
9.3
OPHTHALMOLOGY CLINICS
9.3.1
USE OF HIGH-THROUGHPUT, AI-INTEGRATED, AND PORTABLE IMAGING DEVICES TO FUEL MARKET GROWTH
9.4
OPTOMETRY CLINICS
9.4.1
INCREASING PREVALENCE OF MYOPIA AND LIFESTYLE-RELATED VISION DISORDERS TO AID MARKET GROWTH
9.5
OTHER END USERS
10
OPHTHALMIC IMAGING MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 249 Data Tables
165
10.1
INTRODUCTION
10.2
NORTH AMERICA
10.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2
US
10.2.2.1
US to dominate North American ophthalmic imaging market during forecast period
10.2.3
CANADA
10.2.3.1
Rising geriatric population with chronic eye diseases to propel market growth
10.3
EUROPE
10.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2
GERMANY
10.3.2.1
Strong clinical infrastructure and favorable healthcare policies to boost market growth
10.3.3
FRANCE
10.3.3.1
Government-funded eye screening programs and widespread insurance coverage to accelerate market growth
10.3.4
UK
10.3.4.1
Popularity on national screening programs and focus on NHS-backed digital adoption to stabilize market growth
10.3.5
ITALY
10.3.5.1
High geriatric population and expansion of regional eye care programs to boost demand for ophthalmic imaging
10.3.6
SPAIN
10.3.6.1
Increased public investment in health screening programs to aid market growth
10.3.7
REST OF EUROPE
10.4
ASIA PACIFIC
10.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2
JAPAN
10.4.2.1
Strong focus on preventive and advanced eye care infrastructure to augment market growth
10.4.3
CHINA
10.4.3.1
Popularity of large-scale eye screening programs and focus on advanced ophthalmic imaging infrastructure to drive market
10.4.4
INDIA
10.4.4.1
Rising diabetic population and increasing popularity of nationwide eye health programs to propel market growth
10.4.5
SOUTH KOREA
10.4.5.1
High-tech healthcare adoption and aging demographics to accelerate smart ophthalmic imaging integration
10.4.6
AUSTRALIA
10.4.6.1
Government-backed eye care programs and expanding teleophthalmology to propel market growth
10.4.7
REST OF ASIA PACIFIC
10.5
LATIN AMERICA
10.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2
BRAZIL
10.5.2.1
Focus on public tele-ophthalmology initiatives and diagnostics to boost market growth
10.5.3
MEXICO
10.5.3.1
Increasing prevalence of diabetic eye disease and growing focus on digital health expansion to drive market
10.5.4
REST OF LATIN AMERICA
10.6
MIDDLE EAST & AFRICA
10.6.1
INCREASED HEALTHCARE MODERNIZATION AND FOCUS ON PUBLIC HEALTH INVESTMENTS TO AID MARKET GROWTH
10.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.7
GCC COUNTRIES
10.7.1
GOVERNMENT-LED HEALTHCARE DIGITALIZATION AND INCREASED DIABETES-LINKED VISION DISORDERS TO DRIVE MARKET
10.7.2
MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
11
COMPETITIVE LANDSCAPE
Discover how key players and emerging leaders dominate the ophthalmic imaging market landscape.
274
11.1
INTRODUCTION
11.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1
KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN OPHTHALMIC IMAGING MARKET
11.3
REVENUE ANALYSIS, 2020–2024
11.4
MARKET SHARE ANALYSIS, 2024
11.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1
STARS
11.5.2
EMERGING LEADERS
11.5.3
PERVASIVE PLAYERS
11.5.4
PARTICIPANTS
11.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1
Company footprint
11.5.5.2
Region footprint
11.5.5.3
Product footprint
11.5.5.4
Application footprint
11.5.5.5
End-user footprint
11.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1
PROGRESSIVE COMPANIES
11.6.2
RESPONSIVE COMPANIES
11.6.3
DYNAMIC COMPANIES
11.6.4
STARTING BLOCKS
11.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1
Detailed list of key startups/SMEs
11.6.5.2
Competitive benchmarking of startups/SMEs
11.7
COMPANY VALUATION & FINANCIAL METRICS
11.7.1
FINANCIAL METRICS
11.7.2
COMPANY VALUATION
11.8
BRAND/PRODUCT COMPARISON
11.9
COMPETITIVE SCENARIO
11.9.1
PRODUCT LAUNCHES
11.9.2
DEALS
11.9.3
OTHER DEVELOPMENTS
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
293
12.1
KEY PLAYERS
12.1.1
CARL ZEISS MEDITEC AG
12.1.1.1
Business overview
12.1.1.2
Products offered
12.1.1.3
Recent developments
12.1.1.4
MnM view
12.1.2
TOPCON CORPORATION
12.1.3
NIDEK CO., LTD.
12.1.4
HALMA PLC
12.1.5
ALCON
12.1.6
HEIDELBERG ENGINEERING GMBH
12.1.7
HAAG-STREIT GROUP
12.1.8
CANON MEDICAL SYSTEMS CORPORATION
12.1.9
ESSILORLUXOTTICA
12.1.10
OCULUS
12.1.11
VISIONIX
12.1.12
SONOMED ESCALON
12.1.13
COBURN TECHNOLOGIES, INC.
12.1.14
DGH TECHNOLOGY, INC.
12.1.15
SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.
12.2
OTHER PLAYERS
12.2.1
VISUNEX MEDICAL SYSTEMS
12.2.2
FORUS HEALTH PVT. LTD.
12.2.3
ZIEMER OPHTHALMIC SYSTEMS AG
12.2.4
EYENUK INC.
12.2.5
COSTRUZIONE STRUMENTI OFTALMICI (CSO)
12.2.6
HAI LABORATORIES, INC.
12.2.7
CRYSTALVUE MEDICAL CORPORATION
12.2.8
SUZHOU KANGJIE MEDICAL INC.
12.2.9
KONAN MEDICAL USA, INC.
12.2.10
REMIDIO INNOVATIVE SOLUTIONS PVT. LTD.
13
APPENDIX
334
13.1
DISCUSSION GUIDE
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3
CUSTOMIZATION OPTIONS
13.4
RELATED REPORTS
13.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
OPHTHALMIC IMAGING MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES FROM USD, 2020–2024
TABLE 3
OPHTHALMIC IMAGING MARKET: STUDY ASSUMPTIONS
TABLE 4
OPHTHALMIC IMAGING MARKET: RISK ANALYSIS
TABLE 5
OPHTHALMIC IMAGING MARKET: IMPACT OF ANALYSIS OF MARKET DYNAMICS
TABLE 6
AVERAGE SELLING PRICE OF OPHTHALMIC IMAGING PRODUCTS, BY TYPE, 2024 (USD)
TABLE 7
AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD)
TABLE 8
OPHTHALMIC IMAGING MARKET: ROLE IN ECOSYSTEM
TABLE 9
IMPORT DATA FOR HS CODE 901850, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 10
EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 11
OPHTHALMIC IMAGING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANAURY 2025–DECEMBER 2026
TABLE 12
CASE STUDY 1: ZEISS TO ENHANCE CIRRUS HD-OCT PLATFORM BY INTEGRATING AI-BASED TOOLS FOR DETECTING GLAUCOMA AND RETINAL DISEASES
TABLE 13
CASE STUDY 2: INDIA’S NATIONAL PROGRAM FOR CONTROL OF BLINDNESS (NPCB) TO COLLABORATE WITH FORUS HEALTH FOR REDUCING AVOIDABLE BLINDNESS
TABLE 14
CASE STUDY 3: UK NATIONAL HEALTH SERVICE TO DEPLOY HEIDELBERG ENGINEERING’S SPECTRALIS OCT PLATFORM FOR IMPROVING EARLY DETECTION OF CHRONIC DISEASES
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
OPHTHALMIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 21
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS (%)
TABLE 22
KEY BUYING CRITERIA FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS
TABLE 23
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 24
KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR OPHTHALMIC IMAGING
TABLE 25
OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 26
R&D ACTIVITIES IN AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT
TABLE 27
EXAMPLES OF AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT AVAILABLE IN MARKET
TABLE 28
AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29
EXAMPLES OF NON-AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT AVAILABLE IN MARKET
TABLE 30
NON-AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 32
OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 33
OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34
OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 35
EXAMPLES OF SPECTRAL-DOMAIN OCT (SD-OCT) AVAILABLE IN MARKET
TABLE 36
SPECTRAL-DOMAIN OCT (SD-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
EXAMPLES OF SWEPT-SOURCE OCT (SS-OCT) AVAILABLE IN MARKET
TABLE 38
SWEPT-SOURCE OCT (SS-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
EXAMPLES OF HANDHELD OCT AVAILABLE IN MARKET
TABLE 40
HANDHELD OCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 42
OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 44
EXAMPLES OF OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS AVAILABLE IN MARKET
TABLE 45
OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
EXAMPLES OF OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS AVAILABLE IN MARKET
TABLE 47
OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
EXAMPLES OF OPHTHALMIC ULTRASOUND BIOMICROSCOPES AVAILABLE IN MARKET
TABLE 49
OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
EXAMPLES OF OPHTHALMIC PACHYMETERS AVAIALBLE IN MARKET
TABLE 51
OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
EXAMPLES OF OTHER OPHTHALMIC ULTRASOUND SYSTEMS AVAILABLE IN MARKET
TABLE 53
OTHER OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 55
FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56
FUNDUS CAMERAS MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 57
EXAMPLES OF MYDRIATIC FUNDUS CAMERAS AVAILABLE IN MARKET
TABLE 58
MYDRIATIC FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
EXAMPLES OF NON-MYDRIATIC FUNDUS CAMERAS AVAILABLE IN MARKET
TABLE 60
NON-MYDRIATIC FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
EXAMPLES OF HYBRID FUNDUS CAMERAS AVAILABLE IN MARKET
TABLE 62
HYBRID FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
EXAMPLES OF ROP FUNDUS CAMERAS AVAILABLE IN MARKET
TABLE 64
ROP FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 66
SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
SLIT LAMPS MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 68
EXAMPLES OF HANDHELD SLIT LAMPS AVAILABLE IN MARKET
TABLE 69
HANDHELD SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70
EXAMPLES OF TABLE MOUNT SLIT LAMPS AVAILABLE IN MARKET
TABLE 71
TABLE MOUNT SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
SPECULAR MICROSCOPES MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 74
TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 75
TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76
TONOMETERS MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 77
EXAMPLES OF APPLANATION TONOMETERS AVAILABLE IN MARKET
TABLE 78
APPLANATION TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
EXAMPLES OF REBOUND TONOMETERS AVAILABLE IN MARKET
TABLE 80
REBOUND TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81
OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
OPHTHALMOSCOPES MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 84
EXAMPLES OF DIRECT OPHTHALMOSCOPES AVAILABLE IN MARKET
TABLE 85
DIRECT OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86
EXAMPLES OF INDIRECT OPHTHALMOSCOPES AVAILABLE IN MARKET
TABLE 87
INDIRECT OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88
EXAMPLES OF RETINOSCOPES AVAILABLE IN MARKET
TABLE 89
RETINOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
RETINOSCOPES MARKET, BY REGION, 2023–2030 (UNITS)
TABLE 91
EXAMPLES OF OTHER OPHTHALMIC IMAGING PRODUCTS AVAILABLE IN MARKET
TABLE 92
OTHER OPHTHALMIC IMAGING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93
OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 94
OPHTHALMIC IMAGING MARKET FOR GLAUCOMA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95
OPHTHALMIC IMAGING MARKET FOR CATARACTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96
OPHTHALMIC IMAGING MARKET FOR RETINOPATHIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97
OPHTHALMIC IMAGING MARKET FOR REFRACTIVE DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98
OPHTHALMIC IMAGING MARKET FOR AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99
OPHTHALMIC IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100
OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 101
OPHTHALMIC IMAGING MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102
OPHTHALMIC IMAGING MARKET FOR OPHTHALMOLOGY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103
OPHTHALMIC IMAGING MARKET FOR OPTOMETRY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
OPHTHALMIC IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105
OPHTHALMIC IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 106
NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107
NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 108
NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 109
NORTH AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110
NORTH AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 111
NORTH AMERICA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
NORTH AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
NORTH AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 114
NORTH AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 116
NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 117
US: KEY MACROINDICATORS
TABLE 118
US: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 119
US: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 120
US: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 121
US: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
US: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 123
US: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
US: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
US: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
US: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 127
US: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 128
CANADA: KEY MACROINDICATORS
TABLE 129
CANADA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 130
CANADA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 131
CANADA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
CANADA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
CANADA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
CANADA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 135
CANADA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 136
CANADA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 137
CANADA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 138
CANADA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 139
EUROPE: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140
EUROPE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 141
EUROPE: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 142
EUROPE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 143
EUROPE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
EUROPE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 145
EUROPE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
EUROPE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147
EUROPE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
EUROPE: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 149
EUROPE: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 150
GERMANY: KEY MACROINDICATORS
TABLE 151
GERMANY: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 152
GERMANY: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 153
GERMANY: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
GERMANY: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
GERMANY: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
GERMANY: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
GERMANY: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
GERMANY: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159
GERMANY: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 160
GERMANY: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 161
FRANCE: KEY MACROINDICATORS
TABLE 162
FRANCE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 163
FRANCE: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 164
FRANCE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
FRANCE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
FRANCE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
FRANCE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
FRANCE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
FRANCE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
FRANCE: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 171
FRANCE: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 172
UK: KEY MACROINDICATORS
TABLE 173
UK: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 174
UK: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 175
UK: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
UK: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
UK: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
UK: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179
UK: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
UK: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 181
UK: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 182
UK: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 183
ITALY: KEY MACROINDICATORS
TABLE 184
ITALY: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 185
ITALY: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 186
ITALY: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
ITALY: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE,2023–2030 (USD MILLION)
TABLE 188
ITALY: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
ITALY: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
ITALY: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
ITALY: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
ITALY: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 193
ITALY: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 194
SPAIN: KEY MACROINDICATORS
TABLE 195
SPAIN: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 196
SPAIN: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 197
SPAIN: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
SPAIN: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
SPAIN: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 200
SPAIN: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
SPAIN: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
SPAIN: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203
SPAIN: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 204
SPAIN: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 205
REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 206
REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 207
REST OF EUROPE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
REST OF EUROPE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209
REST OF EUROPE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 210
REST OF EUROPE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
REST OF EUROPE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
REST OF EUROPE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 214
REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 215
ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 216
ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 217
ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 218
ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
ASIA PACIFIC: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
ASIA PACIFIC: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 221
ASIA PACIFIC: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
ASIA PACIFIC: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
ASIA PACIFIC: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 225
ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 226
JAPAN: KEY MACROINDICATORS
TABLE 227
JAPAN: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 228
JAPAN: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 229
JAPAN: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 230
JAPAN: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231
JAPAN: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
JAPAN: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
JAPAN: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234
JAPAN: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235
JAPAN: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 236
JAPAN: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 237
CHINA: KEY MACROINDICATORS
TABLE 238
CHINA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 239
CHINA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 240
CHINA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
CHINA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 242
CHINA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243
CHINA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 244
CHINA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245
CHINA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 246
CHINA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 247
CHINA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 248
INDIA: KEY MACROINDICATORS
TABLE 249
INDIA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 250
INDIA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 251
INDIA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 252
INDIA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 253
INDIA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 254
INDIA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
INDIA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
INDIA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
INDIA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 258
INDIA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 259
SOUTH KOREA: KEY MACROINDICATORS
TABLE 260
SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 261
SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 262
SOUTH KOREA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
SOUTH KOREA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
SOUTH KOREA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
SOUTH KOREA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266
SOUTH KOREA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267
SOUTH KOREA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268
SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 269
SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 270
AUSTRALIA: KEY MACROINDICATORS
TABLE 271
AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 272
AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 273
AUSTRALIA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 274
AUSTRALIA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275
AUSTRALIA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276
AUSTRALIA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 277
AUSTRALIA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278
AUSTRALIA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279
AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 280
AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 281
REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 282
REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 283
REST OF ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284
REST OF ASIA PACIFIC: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285
REST OF ASIA PACIFIC: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286
REST OF ASIA PACIFIC: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287
REST OF ASIA PACIFIC: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 288
REST OF ASIA PACIFIC: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289
REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 290
REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 291
LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 292
LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 293
LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 294
LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295
LATIN AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 296
LATIN AMERICA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 297
LATIN AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 298
LATIN AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 299
LATIN AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 301
LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 302
BRAZIL: KEY MACROINDICATORS
TABLE 303
BRAZIL: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 304
BRAZIL: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 305
BRAZIL: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306
BRAZIL: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 307
BRAZIL: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 308
BRAZIL: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309
BRAZIL: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 310
BRAZIL: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 311
BRAZIL: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 312
BRAZIL: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 313
MEXICO: KEY MACROINDICATORS
TABLE 314
MEXICO: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 315
MEXICO: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 316
MEXICO: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 317
MEXICO: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 318
MEXICO: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 319
MEXICO: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320
MEXICO: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 321
MEXICO: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322
MEXICO: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 323
MEXICO: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 324
REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 325
REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 326
REST OF LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 327
REST OF LATIN AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 328
REST OF LATIN AMERICA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 329
REST OF LATIN AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 330
REST OF LATIN AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 331
REST OF LATIN AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 332
REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 333
REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 334
MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 335
MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 336
MIDDLE EAST & AFRICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 337
MIDDLE EAST & AFRICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 338
MIDDLE EAST & AFRICA: FUNDUS CAMERAS MARKET, BY TYPE,2023–2030 (USD MILLION)
TABLE 339
MIDDLE EAST & AFRICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 340
MIDDLE EAST & AFRICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 341
MIDDLE EAST & AFRICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 342
MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 343
MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 344
GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 345
GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 346
GCC COUNTRIES: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 347
GCC COUNTRIES: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 348
GCC COUNTRIES: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 349
GCC COUNTRIES: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 350
GCC COUNTRIES: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 351
GCC COUNTRIES: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 352
GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 353
GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 354
KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS IN OPHTHALMIC IMAGING MARKET, JANUARY 2021–JULY 2025
TABLE 355
OPHTHALMIC IMAGING MARKET: DEGREE OF COMPETITION
TABLE 356
OPHTHALMIC IMAGING MARKET: REGION FOOTPRINT
TABLE 357
OPHTHALMIC IMAGING MARKET: PRODUCT FOOTPRINT
TABLE 358
OPHTHALMIC IMAGING MARKET: APPLICATION FOOTPRINT
TABLE 359
OPHTHALMIC IMAGING MARKET: END-USER FOOTPRINT
TABLE 360
OPHTHALMIC IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 361
OPHTHALMIC IMAGING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY APPLICATION AND REGION
TABLE 362
OPHTHALMIC IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
TABLE 363
OPHTHALMIC IMAGING MARKET: DEALS, JANUARY 2021–JULY 2025
TABLE 364
OPHTHALMIC IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2025
TABLE 365
CARL ZEISS MEDITEC AG: COMPANY OVERVIEW
TABLE 366
CARL ZEISS MEDITEC AG: PRODUCTS OFFERED
TABLE 367
CARL ZEISS MEDITEC AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2021–JULY 2025
TABLE 368
CARL ZEISS MEDITEC AG: DEALS, JANUARY 2021–JULY 2025
TABLE 369
TOPCON CORPORATION: COMPANY OVERVIEW
TABLE 370
TOPCON CORPORATION: PRODUCTS OFFERED
TABLE 371
TOPOCON CORPORATION: DEALS, JANUARY 2021–JULY 2025
TABLE 372
TOPOCON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2025
TABLE 373
NIDEK CO., LTD.: COMPANY OVERVIEW
TABLE 374
NIDEK CO., LTD.: PRODUCTS OFFERED
TABLE 375
HALMA PLC: COMPANY OVERVIEW
TABLE 376
HALMA PLC: PRODUCTS OFFERED
TABLE 377
ALCON: COMPANY OVERVIEW
TABLE 378
ALCON: PRODUCTS OFFERED
TABLE 379
HEIDELBERG ENGINEERING GMBH: COMPANY OVERVIEW
TABLE 380
HEIDELBERG ENGINEERING GMBH: PRODUCTS OFFERED
TABLE 381
HAAG-STREIT GROUP: COMPANY OVERVIEW
TABLE 382
HAAG-STREIT GROUP: PRODUCTS OFFERED
TABLE 383
CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 384
CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED
TABLE 385
ESSILORLUXOTTICA: COMPANY OVERVIEW
TABLE 386
ESSILORLUXOTTICA: PRODUCTS OFFERED
TABLE 387
OCULUS: COMPANY OVERVIEW
TABLE 388
OCULUS: PRODUCTS OFFERED
TABLE 389
OCULUS: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
TABLE 390
VISIONIX: COMPANY OVERVIEW
TABLE 391
VISIONIX: PRODUCTS OFFERED
TABLE 392
VISIONIX: DEALS, JANUARY 2021–JULY 2025
TABLE 393
SONOMED ESCALON: COMPANY OVERVIEW
TABLE 394
SONOMED ESCALON: PRODUCTS OFFERED
TABLE 395
COBURN TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 396
COBURN TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 397
COBURN TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
TABLE 398
DGH TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 399
DGH TECHNOLOGY, INC.: PRODUCTS OFFERED
TABLE 400
SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
TABLE 401
SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.: PRODUCTS OFFERED
TABLE 402
VISUNEX MEDICAL SYSTEMS: COMPANY OVERVIEW
TABLE 403
FORUS HEALTH PVT. LTD.: COMPANY OVERVIEW
TABLE 404
ZIEMER OPHTHALMIC SYSTEMS AG: COMPANY OVERVIEW
TABLE 405
EYENUK INC.: COMPANY OVERVIEW
TABLE 406
COSTRUZIONE STRUMENTI OFTALMICI (CSO): COMPANY OVERVIEW
TABLE 407
HAI LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 408
CRYSTALVUE MEDICAL CORPORATION: COMPANY OVERVIEW
TABLE 409
SUZHOU KANGJIE MEDICAL INC.: COMPANY OVERVIEW
TABLE 410
KONAN MEDICAL USA, INC.: COMPANY OVERVIEW
TABLE 411
REMIDIO INNOVATIVE SOLUTIONS PVT. LTD.: COMPANY OVERVIEW
LIST OF FIGURES
FIGURE 1
OPHTHALMIC IMAGING MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
OPHTHALMIC IMAGING MARKET: YEARS CONSIDERED
FIGURE 3
OPHTHALMIC IMAGING MARKET: RESEARCH DESIGN
FIGURE 4
OPHTHALMIC IMAGING MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
OPHTHALMIC IMAGING MARKET: KEY PRIMARY DATA SOURCES
FIGURE 6
OPHTHALMIC IMAGING MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 7
OPHTHALMIC IMAGING MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 9
BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 10
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 11
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 12
REVENUE SHARE ANALYSIS ILLUSTRATION: CARL ZEISS MEDITEC AG (2024)
FIGURE 13
OPHTHALMIC IMAGING SUPPLY-SIDE MARKET SIZE ESTIMATION (2024)
FIGURE 14
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
FIGURE 15
OPHTHALMIC IMAGING MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
FIGURE 16
OPHTHALMIC IMAGING MARKET: TOP-DOWN APPROACH
FIGURE 17
OPHTHALMIC IMAGING MARKET: DATA TRIANGULATION METHODOLOGY
FIGURE 18
OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
FIGURE 19
OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 20
OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 21
OPHTHALMIC IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 22
REGIONAL SNAPSHOT OF OPHTHALMIC IMAGING MARKET
FIGURE 23
RISING ADOPTION OF ADVANCED OPHTHALMIC DIAGNOSTICS IN HOSPITALS TO BOOST DEMAND FOR INTEGRATED IMAGING SYSTEMS
FIGURE 24
CHINA AND NON-AI-ENABLED EQUIPMENT COMMANDED LARGEST ASIA PACIFIC MARKET SHARE IN 2024
FIGURE 25
INDIA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
FIGURE 26
ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
FIGURE 27
EMERGING MARKETS TO PROJECT HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 28
OPHTHALMIC IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 29
OPHTHALMIC IMAGING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 30
AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD)
FIGURE 31
OPHTHALMIC IMAGING MARKET: VALUE CHAIN ANALYSIS
FIGURE 32
OPHTHALMIC IMAGING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 33
OPHTHALMIC IMAGING MARKET: ECOSYSTEM ANALYSIS
FIGURE 34
OPHTHALMIC IMAGING MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 (USD MILLION)
FIGURE 35
OPHTHALMIC IMAGING MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 36
OPHTHALMIC IMAGING MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (UNITS)
FIGURE 37
OPHTHALMIC IMAGING MARKET: TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENT APPLIED/GRANTED, JANUARY 2015−JULY 2025
FIGURE 38
OPHTHALMIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 39
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS
FIGURE 40
KEY BUYING CRITERIA FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS
FIGURE 41
IMPACT OF AI/GEN AI ON OPHTHALMIC IMAGING MARKET
FIGURE 42
MARKETS ADJACENT TO OPHTHALMIC IMAGING MARKET
FIGURE 43
NORTH AMERICA: OPHTHALMIC IMAGING MARKET SNAPSHOT
FIGURE 44
ASIA PACIFIC: OPHTHALMIC IMAGING MARKET SNAPSHOT
FIGURE 45
REVENUE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC IMAGING MARKET, 2020–2024 (USD MILLION)
FIGURE 46
MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC IMAGING MARKET (2024)
FIGURE 47
OPHTHALMIC IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 48
OPHTHALMIC IMAGING MARKET: COMPANY FOOTPRINT
FIGURE 49
OPHTHALMIC IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 50
EV/EBITDA OF KEY VENDORS
FIGURE 51
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 52
OPHTHALMIC IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 53
CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT
FIGURE 54
TOPCON CORPORATION: COMPANY SNAPSHOT
FIGURE 55
HALMA PLC: COMPANY SNAPSHOT
FIGURE 56
ALCON: COMPANY SNAPSHOT
FIGURE 57
CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
Methodology
The study involved major activities in estimating the current market size for the ophthalmic imaging market. Exhaustive secondary research was done to collect information on the ophthalmic imaging market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ophthalmic imaging market.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ophthalmic imaging market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ophthalmic imaging market. Primary sources from the demand side included pediatric hospitals, maternity & birthing centers, clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the ophthalmic imaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
When the market size was determined, the entire market was split into three segments. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ophthalmic imaging. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of big corporations' product portfolios and individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Ophthalmic imaging refers to the use of specialized devices and techniques to capture detailed images of the eye to diagnose and monitor ocular diseases. It includes technologies such as optical coherence tomography (OCT), ophthalmic ultrasound systems, fundus cameras, slit lamps, corneal topography systems, specular microscopes, tonometers, ophthalmoscopes, and retinoscopes.
Stakeholders
- Manufacturers of ophthalmic imaging products and related devices
- Suppliers and distributors of ophthalmic imaging devices
- Hospitals, ophthalmology clinics, diagnostic centers, and medical colleges
- Optometry clinics
- Medical device procurement agencies
- Government bodies/municipal corporations
- Business research and consulting service providers
- Venture capitalists
- US Food and Drug Administration (US FDA)
- European Union (EU)
Report Objectives
- To define, describe, and forecast the ophthalmic imaging market based on product, indication, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall ophthalmic imaging market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the ophthalmic imaging market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), the Middle East & Africa, and GCC Countries.
- To strategically profile the key players in the global market and comprehensively analyze their core competencies
- To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market
Frequently Asked Questions (FAQ)
Which are the top industry players in the global ophthalmic imaging market?
The top market players are Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Nidek Co., Ltd. (Japan), Alcon Inc. (Switzerland), Optopol Technology Sp. z o.o (Poland), Essilor International S.A. (France), Bausch & Lomb Incorporated (US), and Halma Plc (UK), among others.
Which segments have been included in this report?
This report includes segments based on technology, product, application, end user, and region.
Which geographical region leads in the ophthalmic imaging market?
North America led the ophthalmic imaging market in 2024. The report also considers Europe, Asia Pacific, Latin America, the Middle East and Africa, and GCC countries.
Which is the leading segment in the ophthalmic imaging market, by product?
The OCT systems segment accounted for the largest share of the ophthalmic imaging market by product.
What is the CAGR of the global ophthalmic imaging market?
The global ophthalmic imaging market is projected to grow at a CAGR of 6.3% from 2025 to 2030.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Ophthalmic Imaging Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Ophthalmic Imaging Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Ophthalmic Imaging Market